★ ANNUAL REVIEW 2027 SPONSORSHIPS NOW OPEN   Learn more →

Log In  |  Become a Member  |  Sponsor  |  ⌕ Search

News/Compliance & Enforcement/Time to Assess BIOSECURE Risk: 1260H Listings Add Urgency to Pharmaceutical Contracting Decisions
Expert Opinion·Compliance & Enforcement Brief

Time to Assess BIOSECURE Risk: 1260H Listings Add Urgency to Pharmaceutical Contracting Decisions

Hogan Lovells – Earlier this week, the Department of War released its 2026 annual update to the 1260H list of Chinese military companies, listing five biotechnology companies, including WuXi AppTec Co., Ltd (“WuXi AppTec”).

🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
Not ready to join? Take the free Pub K Weekly digest.One email. Free. Top industry articles, the community calendar, and the latest job postings.